SINTX Technologies Inc.'s board approved a 1-for-30 reverse split of the company's common stock in order to make the company compliant with the Nasdaq Global Market's listing requirements.
The reverse split became effective July 26 at 5 p.m. ET and began trading on a split-adjusted basis July 29.
The Salt Lake City-based original equipment manufacturer, which develops and sells silicon nitride for biomedical use in the spine and dental markets, will continue using its current trading symbol, SINT, on the Nasdaq Global Market.
American Stock Transfer & Trust Co. LLC is acting as the exchange agent for the reverse split.